Method for treating metabolic bone disease in mammals
Patent 4588716 Issued on May 13, 1986. Estimated Expiration Date: 
January 16, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 16, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3697559 3741996 Hydrogenation process for the preparation of 5,6 cis- and 5,6-trans-10,19-dihydro-vitamin D compounds using transistion metal catalysts Method for treating calcium imbalance and improving calcium absorption in mammals Hydroxyvitamin D2 compounds and process for preparing same Patent #: 4448721 InventorsAssigneeApplicationNo. 06/691824 filed on 01/16/1985US Classes:514/168, With a vitamin type active ingredient514/167, 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI514/169, Cyclopentanohydrophenanthrene ring system DOAI514/170Plural Compounds containing cyclopentanohydrophenanthrene ring systemsExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassesC07C 401/00 (20060101)C07D 317/00 (20060101) C07D 317/24 (20060101) C07J 71/00 (20060101) AbstractA method for treating or preventing metabolic bone disease characterized by loss of bone mass in mammals by administering 24-epi-1,25-dihydroxy vitamin D2 alone or in combinations thereof with bone mobilization-inducing vitamin D derivatives to said mammals. | |
